These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15168808)

  • 61. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Yeasts: neglected pathogens.
    Poulain D; Sendid B; Standaert-Vitse A; Fradin C; Jouault T; Jawhara S; Colombel JF
    Dig Dis; 2009; 27 Suppl 1():104-10. PubMed ID: 20203505
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
    Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.
    Darroch CJ; Barnes RM; Dawson J
    J Clin Pathol; 1999 Jan; 52(1):47-53. PubMed ID: 10343612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.
    Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F
    Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease.
    Mpofu CM; Campbell BJ; Subramanian S; Marshall-Clarke S; Hart CA; Cross A; Roberts CL; McGoldrick A; Edwards SW; Rhodes JM
    Gastroenterology; 2007 Nov; 133(5):1487-98. PubMed ID: 17919633
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value.
    Glas J; Török HP; Vilsmaier F; Herbinger KH; Hoelscher M; Folwaczny C
    Digestion; 2002; 66(3):173-7. PubMed ID: 12481163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune sensitization to food, yeast and bacteria in Crohn's disease.
    van den Bogaerde J; Kamm MA; Knight SC
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1647-53. PubMed ID: 11564006
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.
    Tang V; Valim C; Moman R; Richman A; Zhou J; Ramgopal V; Albert R; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):248-253. PubMed ID: 27111346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.
    Vasiliauskas EA; Kam LY; Karp LC; Gaiennie J; Yang H; Targan SR
    Gut; 2000 Oct; 47(4):487-96. PubMed ID: 10986208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.
    Ng SC; Hirai HW; Tsoi KK; Wong SH; Chan FK; Sung JJ; Wu JC
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1664-70. PubMed ID: 24910240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease].
    Sendid B; Jouault T; Vitse A; Fradin C; Colombel JF; Poulain D
    Med Sci (Paris); 2009 May; 25(5):473-81. PubMed ID: 19480828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin.
    Adams RJ; Heazlewood SP; Gilshenan KS; O'Brien M; McGuckin MA; Florin TH
    Am J Gastroenterol; 2008 Feb; 103(2):386-96. PubMed ID: 17924999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
    Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
    Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man.
    Sander U; Kunze I; Bröker M; Kunze G
    Immunol Lett; 1998 Apr; 61(2-3):113-7. PubMed ID: 9657263
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae.
    Young M; Davies MJ; Bailey D; Gradwell MJ; Smestad-Paulsen B; Wold JK; Barnes RM; Hounsell EF
    Glycoconj J; 1998 Aug; 15(8):815-22. PubMed ID: 9870358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of dietary yeast on the activity of stable chronic Crohn's disease.
    Barclay GR; McKenzie H; Pennington J; Parratt D; Pennington CR
    Scand J Gastroenterol; 1992; 27(3):196-200. PubMed ID: 1502481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target.
    Burnham-Marusich AR; Hubbard B; Kvam AJ; Gates-Hollingsworth M; Green HR; Soukup E; Limper AH; Kozel TR
    mSphere; 2018; 3(3):. PubMed ID: 29720523
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunosorbent for the isolation of specific antibodies against mannan: localization of antigens in yeast cell walls.
    Gerber H; Horisberger M; Bauer H
    Infect Immun; 1973 Mar; 7(3):487-92. PubMed ID: 4123394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.